Evidence map›Paper›PMID 38715782›Full record

ArticleFrontiers in oncology2024

Case report: Report of a rare encounter: metastasis of renal cell carcinoma to the thyroid.

Siyi Xu, Jiawei Xu, Chengdong Yu, Ying Zeng, Lei Tang, Mu Tang, Tenghua Yu, Zhengkui Sun, Xiaofang Zhang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Siyi Xu *Department of pathology, Jiangxi Cancer Hospital, Nanchang, China.
Jiawei Xu *Jiangxi Medical College, Nanchang University, Nanchang, China.
Chengdong Yu *Jiangxi Medical College, Nanchang University, Nanchang, China.
Ying Zeng *Jiangxi Medical College, Nanchang University, Nanchang, China.
Lei TangJiangxi Medical College, Nanchang University, Nanchang, China.
Mu TangJiangxi Medical College, Nanchang University, Nanchang, China.
Tenghua YuJiangxi Medical College, Nanchang University, Nanchang, China.
Zhengkui SunJiangxi Medical College, Nanchang University, Nanchang, China.
Xiaofang ZhangDepartment of pathology, Jiangxi Cancer Hospital, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinoma (RCC) is the most common renal tumor, with lung, bone, and liver being the primary sites of metastasis. Thyroid metastasis, on the other hand, is relatively uncommon. Metastatic tumors in the thyroid gland typically manifest as multiple or isolated nodules, which can be easily overlooked due to the lack of specific clinical and imaging features. However, the identification of thyroid metastasis suggests the presence of systemic metastasis and is indicative of a poor prognosis for patients. In this paper, we present two cases of thyroid metastasis following nephrectomy, with the objective of enhancing understanding among medical community regarding the diagnosis and treatment of thyroid metastasis originating from renal cell carcinoma. By raising awareness about this phenomenon, we emphasize the importance of early detection and diagnosis to improve patient prognoses. The implementation of standardized treatment protocols at the earliest possible stage is also emphasized. Through this research, we aim to contribute to the early identification and management of thyroid metastasis in patients with renal cell carcinoma, ultimately leading to improved outcomes.

Indexed as

case reportdiagnosismetastasispathologyrenal cell carcinomathyroid

Identifiers

PMID38715782
PMCPMC11074456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.